Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients

Comparison of whole blood and plasma potassium concentrations in dogs using the Reflovet system.

Veterinary clinical pathology·2003

Prevalence of orthostatic hypotension in Parkinson's disease.

Journal of neurology, neurosurgery, and psychiatry·1998

Central cardiovascular effects of acetylcholine in the conscious dog.

British journal of pharmacology·1995

Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs.

British journal of pharmacology·1995

[Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years].

Therapie·1995

Antiarrhythmic drug-induced side effects: a prospective survey of 300 patients.

Therapie·1995

Candesartan for Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Clinical neuropharmacology·2026

Clozapine-Memantine Therapy in Catatonia: Clinical Insights From a Case Report and Literature Review.

Clinical neuropharmacology·2026

Last of the Just: A Novel Highlighting Descriptive Relations Between Trauma-induced Episodes of Dissociation and Psychosis. Does Pathologic Disruption of NMDA Receptor-mediated Neurotransmission Underlie These Relations and Serve as a Promising Therapeutic Target?

Clinical neuropharmacology·2026

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026

Depression in Parkinson's Disease: Real-World Prescribing Patterns and Treatment Dynamics from a Nationwide Greek Cohort.

Movement disorders clinical practice·2026

Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2026

Population Pharmacokinetics and Exposure-Response of Sasanlimab, a Checkpoint Inhibitor, in Patients with Non-Muscle Invasive Bladder Cancer and Other Solid Tumors.

Journal of clinical pharmacology·2026

Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.

Journal of Parkinson's disease·2026

Green and sustainable enzyme-assisted extraction of antidiabetic phytochemicals: current trends and future prospects.

Preparative biochemistry & biotechnology·2026

Computational, In Vitro, and In Vivo Evaluation of Benzimidazole-Pyrazole Hybrid Scaffolds as Multi-Target Anti-Ulcer Agents.

Chemistry & biodiversity·2026

Related Experiment Videos

Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients

Related Concept Videos

Comparison of whole blood and plasma potassium concentrations in dogs using the Reflovet system.

Prevalence of orthostatic hypotension in Parkinson's disease.

Central cardiovascular effects of acetylcholine in the conscious dog.

Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs.

[Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years].

Antiarrhythmic drug-induced side effects: a prospective survey of 300 patients.

Candesartan for Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Clozapine-Memantine Therapy in Catatonia: Clinical Insights From a Case Report and Literature Review.

Last of the Just: A Novel Highlighting Descriptive Relations Between Trauma-induced Episodes of Dissociation and Psychosis. Does Pathologic Disruption of NMDA Receptor-mediated Neurotransmission Underlie These Relations and Serve as a Promising Therapeutic Target?

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Depression in Parkinson's Disease: Real-World Prescribing Patterns and Treatment Dynamics from a Nationwide Greek Cohort.

Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.

Population Pharmacokinetics and Exposure-Response of Sasanlimab, a Checkpoint Inhibitor, in Patients with Non-Muscle Invasive Bladder Cancer and Other Solid Tumors.

Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.

Green and sustainable enzyme-assisted extraction of antidiabetic phytochemicals: current trends and future prospects.

Computational, In Vitro, and In Vivo Evaluation of Benzimidazole-Pyrazole Hybrid Scaffolds as Multi-Target Anti-Ulcer Agents.

Related Experiment Videos

Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients

Related Concept Videos

Related Articles